Towa Pharmaceutical Co., Ltd.

TWAPF · OTC
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Operating Activities
Net Income$26$16$5$22
Dep. & Amort.$20$18$19$11
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$0$0
Change in WC-$4-$33-$14-$3
Other Non-Cash-$19$7-$8-$8
Operating Cash Flow$23$8$3$22
Investing Activities
PP&E Inv.-$29-$38-$30-$14
Net Acquisitions$0-$2-$1-$45
Inv. Purchases-$0-$0-$0-$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$2-$1$2-$1
Investing Cash Flow-$31-$40-$30-$60
Financing Activities
Debt Repay.$15$39$21$49
Stock Issued$0$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid-$3-$3-$3-$2
Other Fin. Act.$9-$0-$0-$0
Financing Cash Flow$22$35$17$47
Forex Effect$2$2$2$1
Net Chg. in Cash$16$5-$9$10
Supplemental Information
Beg. Cash$30$24$33$23
End Cash$45$30$24$33
Free Cash Flow-$8-$31-$28$9